USPTO serial 77058274
SUPALIV
Reviewed by CopyMark Law Group
Reg. 3491054Status 710
- Filing date
- Status date
- Registration date
- Aug 26, 2008
- Examiner
- THOMPSON, HEATHER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SUPALIV?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LIECHTENSTEIN, LI
LIECHTENSTEIN, LI
LIECHTENSTEIN, LI
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph R. Englander, Esq.
JOSEPH R ENGLANDER ESQ CHRISTOPHER & WEISBERG PA200 E LAS OLAS BLVD STE 2040FORT LAUDERDALE, FL 33301-2240UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical preparations and reagents for scientific purposes for the pharmaceutical industry, veterinary industry and food industry; chemical, biological and biochemical preparations for the scientific research of diseases and the development of medicaments, pharmaceutical and veterinary products; amino acids for scientific research purposes, in particular for the pharmaceutical industry and food industry | SECTION 8 - CANCELLED | — |
| 005 | Medicaments for the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, neuropathy, neurodegenerative diseases, Alzheimer's disease, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, cardio-vascular diseases, AIDS and vascular dysfunctions; pharmaceutical and veterinary preparations for the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, neuropathy, neurodegenerative diseases, Alzheimer's disease, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, cardio-vascular diseases, AIDS and vascular dysfunctions; chemical, biological and biochemical preparations and reagents for medical and veterinary purposes; food supplements; dietetic products for medical purposes, namely, compositions of nutrients, vitamins, minerals, carbohydrates, sugar, lipids, organic acids, antioxidative compounds, enzymes, co-enzymes, metabolites, proteins, amino acids; dietary supplemental drinks and dietetic food for medical purposes; vitamins and amino acids for medical purposes | SECTION 8 - CANCELLED | — |
| 042 | Scientific and industrial research in the fields of medicine, pharmacology and food technology; research and development of medicaments and methods of treatment; scientific and technical consulting in the field of pharmacology and food technology | SECTION 8 - CANCELLED | — |
| 044 | Medical and veterinary services; medical consultation services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TIMA FOUNDATION
- Other trademarks owned by TIMA FOUNDATION
- Other trademarks owned by TIMA FOUNDATION
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SUPALIV
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 27, 2015 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 26, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2008 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jul 18, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 15, 2008 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 15, 2008 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Mar 25, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 1, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 12, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 28, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 27, 2007 | ALIE | ASSIGNED TO LIE | — |
| Oct 23, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 23, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 23, 2007 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 23, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 23, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 16, 2007 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 16, 2007 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 16, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 25, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 25, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 25, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 30, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 11, 2006 | NWAP | NEW APPLICATION ENTERED | — |